Physician profile
Monte L Slatton
NPI 1093703050
$3,861.49
in general payments reported to CMS, 2019-2025
11 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $166 · 2021: $241 · 2022: $304 · 2023: $810 · 2024: $936 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Travel and Lodging: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.95 |
| Travel and Lodging | $1,093.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,631.38 | 2020-2025 | Ultreon, Optis, Jeti All In One Non-Sterile Kit |
| Medtronic, INC. | $1,091.23 | 2023-2025 | Micra |
| Biotronik INC. | $807.51 | 2019-2024 | |
| Cleerly, INC. | $79.29 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Boston Scientific Corporation | $78.97 | 2022-2023 | Watchman Flx |
| Abiomed | $62.93 | 2023-2025 | Impella |
| Cordis US Corp. | $26.72 | 2022 | |
| Medtronic Vascular, INC. | $22.41 | 2019 | |
| Cook Medical LLC | $21.61 | 2024 | Rosen |
| Cardinal Health 200 LLC | $20.28 | 2019 | |
| Baxter Healthcare | $19.16 | 2025 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monte Slatton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.